Skip to content
Search

Latest Stories

All migrants in UK eligible for Covid-19 vaccine

Migrants living in Britain will be eligible to receive Covid-19 vaccines regardless of whether they have the legal right to live and work in the country, the government said on Monday, adding that getting the shot would not trigger immigration checks.

The Daily Mail newspaper has reported that those living in Britain who entered the country illegally would be encouraged to register with their local doctor so they could be vaccinated when their turn comes.


Asked about that report, which described the policy as an “amnesty”, a government spokeswoman said: “Coronavirus vaccines will be offered to everyone living in the UK free of charge, regardless of immigration status.

“Those registered with a GP are being contacted at the earliest opportunity and we are working closely with partners and external organisations to contact those who are not registered with a GP to ensure they are also offered the vaccine.”

The government said patients undergoing vaccinations, treatment or testing for the coronavirus were not subject to immigration status checks.

Britain has already given first vaccine shots to more than 12 million people. The vaccination programme is running ahead of its European peers, in part due because Britain was the first to approve shots from Pfizer and AstraZeneca.

Britain’s vaccination strategy makes no formal priority of migrants, instead focusing on reaching the eldest and most vulnerable first.

However, some European countries have made a priority of vaccinating refugees, given the risk that new arrivals being housed in asylum centres could spread infection.

In Germany, asylum seekers have been included in the second group to be vaccinated - along with people over 70 and police officers - and should start getting shots in March, according to the government’s vaccination strategy.

More For You

GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less
Community Pharmacy Scotland secures £10m reimbursement uplift amid ongoing negotiations

Negotiations continue on the Global Sum element of remuneration.

Getty Images

Community Pharmacy Scotland secures £120m reimbursement deal for 2025/26

Community Pharmacy Scotland (CPS) has accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

The agreement marks the first phase of ongoing negotiations surrounding community pharmacy funding for the upcoming financial year.

Keep ReadingShow less